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Functional characterisation of Schistosoma
japonicum acetylcholinesterase
Hong You1*, Geoffrey N. Gobert1,2, Xiaofeng Du1, Gabor Pali1, Pengfei Cai1, Malcolm K. Jones3
and Donald P. McManus1*
Abstract
Background: Acetylcholinesterase (AChE) is an important metabolic enzyme of schistosomes present in the
musculature and on the surface of the blood stage where it has been implicated in the modulation of glucose
scavenging from mammalian host blood. As both a target for the antischistosomal drug metrifonate and as a
potential vaccine candidate, AChE has been characterised in the schistosome species Schistosoma mansoni, S.
haematobium and S. bovis, but not in S. japonicum. Recently, using a schistosome protein microarray, a predicted
S. japonicum acetylcholinesterase precursor was significantly targeted by protective IgG1 immune responses in S.
haematobium-exposed individuals that had acquired drug-induced resistance to schistosomiasis after praziquantel
treatment.
Results: We report the full-length cDNA sequence and describe phylogenetic and molecular structural analysis to
facilitate understanding of the biological function of AChE (SjAChE) in S. japonicum. The protein has high sequence
identity (88 %) with the AChEs in S. mansoni, S. haematobium and S. bovis and has 25 % sequence similarity with
human AChE, suggestive of a highly specialised role for the enzyme in both parasite and host. We immunolocalized
SjAChE and demonstrated its presence on the surface of adult worms and schistosomula, as well as its lower
expression in parenchymal regions. The relatively abundance of AChE activity (90 %) present on the surface of
adult S. japonicum when compared with that reported in other schistosomes suggests SjAChE may be a more
effective drug or immunological target against this species. We also demonstrate that the classical inhibitor of
AChE, BW285c51, inhibited AChE activity in tegumental extracts of paired worms, single males and single females
by 59, 22 and 50 %, respectively, after 24 h incubation with 200 μM BW284c51.
Conclusions: These results build on previous studies in other schistosome species indicating major differences in
the enzyme between parasite and mammalian host, and provide further support for the design of an anti-schistosome
intervention targeting AChE.
Keywords: Schistosoma japonicum, Acetylcholinesterase, Drug or vaccine target
Background
Schistosomiasis remains one of the most insidious and
serious of the tropical parasitic diseases of clinical and
public health significance. Currently, there is no effective
vaccine to prevent schistosomiasis [1] and treatment is
dependent on praziquantel chemotherapy. Previous re-
ports showed that human schistosomiasis could be
treated using the drug metrifonate [2], which can disrupt
the cholinergic system and neuromuscular signalling by
targeting acetylcholinesterase (AChE). Metrifonate was,
however, withdrawn from the market because of un-
acceptable toxicity to the host and variable efficacy
against different schistosome species [3].
During the blood dwelling stages of schistosomes,
acetylcholinesterase (AChE) is present on the parasite
tegument membrane [4] and in the musculature [5],
both in adults and schistosomula. A previous study im-
plicated schistosome AChE in regulating glucose scaven-
ging from the host [6]. It has been shown that the basal
rate of glucose uptake in adult Schistosoma haemato-
bium and S. bovis is about twice that in S. mansoni [7].
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Indicative of the higher metabolic requirements for glu-
cose in S. haematobium and S. bovis, relatively higher
amounts of AChE activity are present on their tegu-
ments compared with S. mansoni [2]. These higher
levels of AChE activity result in the recorded higher sus-
ceptibility to metrifonate [8]. It has also been shown that
S. mansoni AChE antibodies can lead to efficient
complement-mediated killing of schistosomula in vitro
[9]. Importantly, the absence of cross-reactivity with hu-
man AChE further supports schistosome AChE as a
suitable target for immunological attack [9].
AChE has been characterised from S. mansoni, S. haema-
tobium and S. bovis [10, 11], but not in S. japonicum. Re-
cently, using a schistosome protein microarray, a predicted
S. japonicum acetylcholinesterase precursor (AY810792)
was significantly targeted by protective IgG1 immune re-
sponses in S. haematobium-exposed individuals that had
acquired drug-induced resistance to schistosomiasis after
praziquantel treatment [12]. This observation further sup-
ports consideration of S. japonicum AChE (SjAChE) as a
suitable vaccine candidate against schistosomiasis.
The interaction between acetylcholine (ACh) and its re-
ceptor, the nicotinic acetylcholine receptor (nAChR), re-
sults in the opening of the ion channel in mammalian
cells [7]. Schistosome AChE plays an important role in
limiting this interaction as the inhibition of AChE mimics
ligand excess and causes receptor desensitisation [11]. It
has been shown that circulating concentrations of ACh
can result in an increase in glucose uptake in schistosomes
in vitro, and this effect is ablated in the presence of anti-
acetylcholinesterase antibodies [7]. Furthermore, the influ-
ence of acetylcholine on glucose uptake in these worms
can be modulated through inhibition of either tegumental
AChE or nAChR [11]. nAChRs are ligand-gated ion chan-
nels within the nervous system that mediate the excitatory
responses to acetylcholine. Three types of acetylcholine
receptors have been identified in S. haematobium:
ShAR1α (AY392150) [13, 14], ShAR1β (AY392151) [14]
and ShAR2β [15]. It has been demonstrated that ShAR1α
is located on the parasite surface and may contribute to
the potentiation of the uptake of glucose from the host
blood in response to circulating concentrations of ACh.
As the first step in determining the functional charac-
teristics of AChE from S. japonicum, we present the iso-
lated full-length sequence of the protein from this
schistosome species, describe the distribution of the en-
zyme in schistosomula and adult worms, and show that
the classic inhibitor of BW284c51 effectively suppresses
AChE activity in adult worms in vitro.
Methods
Parasites
Schistosoma japonicum adult worms were collected by
perfusion of female ARC Swiss mice infected percu-
taneously with 60 cercariae of S. japonicum (Anhui
population, mainland China) shed from Oncomelania
hupensis hupensis snails as described [16]. In order to ob-
tain schistosomula, cercariae were passed through a 22-
gauge emulsifying needle 25 times to mechanically shear
the cercarial tails from the bodies. The resulting larvae
were separated from the free tails by centrifugation,
washed three times with a modified Basch’s medium [17]
and incubated at 37 °C under a 5 % CO2 atmosphere be-
fore experimentation.
Cloning S. japonicum AChE
A Qiagen RNeasy kit (Qiagen, Hilden, Germany) was
used to purify total RNA from adult S. japonicum. A one
step RT-PCR (Qiagen) kit was employed to amplify spe-
cific cDNA. Based on the conserved sequences of AChE
in S. mansoni (AF279461), S. haematobium (AF279462)
and S. bovis (AF279463), and partial S. japonicum se-
quences available at http://www.genedb.org/Homepage/
Sjaponicum, four pairs of primers for SjAChE were de-
signed (Table 1) to obtain the full-length cDNA se-
quence to PCR amplify the full-length sequence of
SjAChE using an overlap strategy.
Sequence and phylogenetic analysis
Searches for homologous acetylcholinesterase protein se-
quences were performed using BLAST on the NCBI web
site (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and the Worm-
Base ParaSite web site (http://parasite.wormbase.org/
Multi/Tools/Blast). Phylogenetic analysis was performed
using online resources (http://www.phylogeny.fr/simple_-
phylogeny.cgi) [18] by uploading the set of available AChE
sequences from the different species presented. Molecular
weight and isoelectric point determinations were per-
formed using the ExPASy-Compute pI/Mw tool (http://
web.expasy.org/compute_pi/). The PHYRE2 protein fold
Table 1 Primers used in PCR to obtain the full-length cDNA sequence encoding S. japonicum acetylcholinesterase
Primer ID Primer pair sequence (5′-3′)
Forward Reverse Size (bp)
SjAChE1 ACATGTAGATTCATTCACTATGAAAATG ACATTGGAGTATTTGGTACCCAC 655
SjAChE2 AAATTACCAGCCAGTTGTCCA CCGCCGAAATCTTCAATGTG 404
SjAChE3 TTTCTTTATATGAACACAGAAGAAGCACCAGGTAA TTCATAACCATGCATTGTACCAGTCC 936
SjAChE4 ACAGCTGTAACAAATGATTATCGTATACCAGGTC CACGCCTAAACAATGCTGACGATT 561
You et al. Parasites & Vectors  (2016) 9:328 Page 2 of 12
recognition server (http://www.sbg.bio.ic.ac.uk/phyre2/)
was used to generate the three-dimensional (3D) model of
SjAChE [19] and binding site predictions were carried out
using the 3DLigandSite (http://www.sbg.bio.ic.ac.uk/3dli-
gandsite/) [20].
Protein expression, purification and antibody generation
A C-terminal fragment of SjAChE (from Q465 to V680,
named SjAChEC) was amplified and cloned into the
pET28b vector (Novagen, Madison, USA), by using for-
ward (5′-CGG GAT CCT CAG TTG CCG ACA CTT
GAA AGT TGG A-3′ with BamHI restriction site
underlined) and reverse (5′-CGC TCG AGC ACG CCT
AAA CAA TGC TGA CGA TTA CG-3′ with XhoI re-
striction site underlined) primers. The reconstructed
vector was then transformed into Escherichia coli (BL21
strain) for expression induced with 1 mM IPTG (isopro-
pyl thio-b-D-galactoside) at 37 °C for 3 h. Recombinant
protein was purified from inclusion bodies by chroma-
tography using a Ni-NTA His-tag affinity kit (Novagen)
under denaturing conditions using 6 M guanidine ac-
cording to the manufacturer’s instructions.
Antibodies were raised against the SjAChEC fusion
protein in a rabbit at the South Australian Health and
Medical Research Institute (SAHMRI). Briefly, the rabbit
was immunized three times each with 500 μg recombin-
ant protein at three week intervals. Based on the fact
that complete Freund’s adjuvant is the most effective
adjuvant available for consistently producing high titer
antibodies to diverse antigens, we used complete
Freund’s adjuvant in the initial injection, but in the sub-
sequent two used incomplete Freund’s adjuvant. The in-
jections were delivered subcutaneously at multiple sites
along the neck and spine. Blood was collected two weeks
after the final boost. The titre of the antibody was deter-
mined using an enzyme-linked immunosorbent assay
(ELISA). Briefly, Maxisorb immunoplates (Nalge Nune
International, USA) were coated overnight at 4 °C with
rSjAChE protein (100 μl of 0.5 μg/ml) in coating buffer
(100 μl/well). After three washes with 0.05 % (v/v)
Tween in PBS (PBST), wells were blocked with 200 μl of
5 % (v/v) skim milk in PBS (SMP) and incubated for 1 h
at 37 °C. The rabbit anti-SjAChE serum was serially di-
luted (from 1:200 to 1:102,400) in SMP and 100 μl in
duplicate of each dilution were added to individual wells.
After incubation at 37 °C for 1 h, the wells were washed
with PBST (3X) and 100 μl (1:2,000 dilution) of horse-
radish peroxidise (HRP)-conjugated goat anti-rabbit IgG
(Invitrogen) was added. After incubation at 37 °C for
1 h, the wells were washed with PBST (5X), 100 μl of
substrate solution [2,2-azino-di-(ethyl-benzithiozolin sul-
fonate)] (Sigma, Castle Hill, Australia) was added and
the wells were incubated at room temperature and read
on a plate reader by using Microplate manager software
(Bio-Rad, Mississauga, Canada). Data are presented as
antibody endpoint titres, defined as the highest dilution
of test serum that yielded an average O.D. two standard
deviations (SDs) greater than that obtained in the ab-
sence of primary antibody.
Western blot analysis
The rabbit anti-SjAChEC serum was used in Western
blotting to probe to the electrophoresed purified recom-
binant SjAChEC protein and the native SjAChE protein
in a separated crude S. japonicum antigen extract. The
crude antigen was prepared from adult worms of S.
japonicum freshly perfused from mice percutaneously
infected with 60 cercariae six weeks previously. After
three washes in perfusion buffer (8.5 g NaCl and 15 g
NaCitrate in 1 l of water), to minimise contamination of
the schistosome protein extract with host components,
an adult worm antigen preparation (SWAP) was made
as described [21]. The recombinant SjAChEC and
SWAP samples were separated on a 15 % (w/v) SDS-
PAGE gel and transferred to an Immun-Blot® low
fluorescence-PVDF membrane. Overnight blocking was
performed with Odyssey buffer at 4 °C. Then, the mem-
brane was subjected to incubation with the rabbit anti-
SjAChE anti-serum (1:100 dilution in Odyssey buffer
and 0.1 % Tween-20) for 1 h followed by incubation
with IRDye-labeled 680LT goat anti-rabbit IgG antibody
(Li-COR Biosciences) (1:15,000 diluted in Odyssey buffer
with 0.1 % Tween-20 and 0.01 % SDS) for 1 h on a
shaker in a dark chamber. After a final wash with dis-
tilled water, the membrane was allowed to dry in the
dark and visualized using the Odyssey® CLx Infrared Im-
aging System [22].
Immunolocalisation
Adult S. japonicum
Horseradish peroxidise (HRP) labelling was used for the
immunolocalisation of SjAChE in adult S. japonicum.
Freshly perfused male and female worms were fixed in
100 % methanol, embedded in Tissue-Tek Optimal
Cutting Temperature (OCT) compound (ProSciTech,
Queensland, Australia), and 7.0 μm cryostat sections
produced. The HRP labelling was performed according
to standard procedures [21]. The primary antibody solu-
tion was a 1:200 dilution of the rabbit anti-SjAChE
serum, and normal rabbit serum was used as control.
Non-specific antibody binding was inhibited by incubat-
ing the section in 10 % (v/v) normal goat serum in PBS.
ImmPRESSTM HRP Anti-Rabbit IgG (Peroxidase) Poly-
mer (Vector Labs, California USA) was used as second
antibody for the immunolocalisation. Slides were
scanned and digitised using a ScanScope XT (Aperio,
California, USA).
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Schistosomula
Four-day old transformed larvae were cultured in Basch’s
medium [3] containing rabbit anti-SjAChEC serum
(1:100 dilution), or pre-immune rabbit serum (1:100 di-
lution) as negative control, at 4 °C overnight [23]. The
larvae were washed three times with Basch medium and
incubated with 1:300 donkey anti-rabbit IgG Alexa Fluor
555 (2 mg/ml, Invitrogen) for 1 h at room temperature,
followed by three further washes in the medium. The
larvae were fixed in 4 % paraformaldehyde in PBS for
10 min at room temperature, and then visualised under
fluorescence using a Zeiss 780 NLO confocal micro-
scope (Zeiss, Germany).
Fluorescence-based enzyme assays
The enzymatic activity of AChE in S. japonicum was de-
termined using the Amplex Red Acetylcholine/Acetyl-
cholinesterase Assay Kit (Invitrogen) according to the
manufacturer’s instructions. The assay is fluorescence-
based and utilises the highly fluorescent end product
resorufin which is processed in black Costar 96-well
plates (Sigma) and measured using the POLARstar
OPTIMA (BMG Labtech, Ortenberg Germany) at an
absorption of 560 nm and an emission of 590 nm. Nega-
tive and positive control samples are provided in the
assay kit and BW284c51 [1,5-bis(4allyldimethylammo-
niumphenyl)pentan-3-one dibromide] (Sigma), a specific
inhibitor of AChE, was also used in the enzyme assay.
Different protein extracts of S. japonicum used in the
enzymatic assays:
(1) Tegument protein and residual carcass protein ex-
tracted from adult S. japonicum freshly perfused from
mice. The tegument was removed from paired adult
worms by the freeze/thaw/vortex method [24]. Briefly,
freshly perfused paired adult S. japonicum (50 pairs)
were frozen in liquid nitrogen, thawed on ice and 400 μl
of ice-cold TBS (10 mM Tris-HCl, 0.84 % NaCl, pH 7.4)
was added to each tube. The supernatant was removed
after 1 min and then 400 μl of Tris-HCl, pH 7.4 was
added and the tube left to incubate on ice for 5 min.
Tubes were vortexed 8 times for 1 s to ensure tegument
release. The tegument-rich supernatant was transferred
to another tube where it was centrifuged for 30 min at
12,000 g, 4 °C, the supernatant was discarded and the
tegument-rich pellet re-suspended in 60 μl 10 mM Tris-
HCl, pH 8.0. The remaining carcasses were homogenised
using the protocol for making SWAP essentially as de-
scribed in [21], and above. The protein concentrations of
the enriched tegument fraction and the residual carcass
preparation were measured using the Bio-Rad protein
assay dye reagent (Bio-Rad, California, USA). These pro-
tein extracts (0.005 mg/ml) were pre-incubated at
room temperature for 30 min with BW284c51 at
concentrations of 0, 10, 100 and 1000 μM and then
used in the AChE activity assays.
(ii) Freshly perfused adult S. japonicum were cultured
in RPMI medium containing 10 % (v/v) heat-
inactivated fetal calf serum overnight. The worms were
then divided into three groups: single males, single fe-
males and paired male and female worms (40 single
worms or 20 pairs/group). Each group was then
treated with or without 200 μM BW284c51 for 24 h,
after which time the worms were rinsed 3 times in
RPMI medium, collected and used for tegumental pro-
tein and carcass protein extraction as described above.
AChE activities of all the protein samples (0.005 mg/
ml) from the various worm samples were measured
using the Amplex Red Acetylcholine/Acetylcholin-
esterase Assay Kit.
Worm collections, protein extractions and AChE
activity measurements in (i) and (ii) were performed
three times. T-test was employed to make the com-
parison between samples by using GraphPad software
(version 7.0).
Results
Full-length sequence of SjAChE
The complete SjAChE cDNA sequence was obtained,
comprising an open reading frame (ORF) of 2,040 bp
(submitted to GenBank under accession number
KX268651) encoding 680 amino acids. SjAChE shares
88 % amino acid sequence identity with the AChEs from
S. mansoni, S. haematobium and S. bovis, and 55 % iden-
tity with the AChEs in Echinococcus granulosus [25] and
E. multilocularis [26]. In contrast, SjAChE shares only
25 % amino acid identity to human AChE and 26 %
identity to the AChE from Torpedo californica (Pacific
electric ray). Phylogenetic analysis was performed
using AChE protein sequences from a variety of spe-
cies to produce a cladogram to infer evolutionary re-
lationships between taxa (Fig. 1). Of the schistosome
sequences, the AChE coding region for S. japonicum
is most similar to that of S. haematobium. The Schis-
tosoma spp. sequences are separated considerably
from those of Echinococcus species and, as expected,
have more sequence similarity with the AChEs of
other trematode species including Clonorchis sinensis,
Opisthorchis viverrini and Fasciola hepatica. Crucially,
all residues within the AChE protein sequence that
are currently known to be important for substrate
binding and catalytic activity, i.e. those comprising
the peripheral anionic site [27], the catalytic triad
substrate inhibition of acetylcholinesterase residues in-
volved in signal transduction from the surface to the
catalytic center [28], and those lining the catalytic
gorge [29], are conserved across all Schistosoma
species.
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Using an in silico motif and domain search tool
(http://prosite.expasy.org/), we identified two conserved
sub-domains in the SjAChE protein sequence - a carbox-
ylesterase type-B signature 2 (E156-P166) region, and a
carboxylesterase type-B serine active site (F258-G273),
both of which are shown boxed in red in Fig. 2. Several
other motifs were also found in SjAChE (Fig. 2); these
included:
1) N-glycosylation sites underlined (N42-I45, N171-
H174, N314-Q317, N418-D421, N630-K633);
2) N-myristoylation sites boxed in purple (G71-Q76,
G95-Q100, G298-N303, G305-E310, G395-E400,
G532-Y537);
3) A casein kinase II phosphorylation site boxed in
brown (S88-D91, S200-D203, S329-D332, S341-
E344, T351-D354, T456-E459, S471-E474, T559-
E562, T592-E595);
4) Protein kinase C phosphorylation sites boxed in blue
(S105-R107, T316-R318, S379-R381, T473-R475,
S481-K486, S631-K633) which are specific for
schistosomes;
5) A tyrosine kinase phosphorylation site boxed in
green (R454-Y460);
6) An amidation site boxed in yellow (P503-R506).
After comparisons with other species and the schisto-
some sequences published by Bentley et al [30], we dem-
onstrated that the catalytic and peripheral active site
residues in S. japonicum, S. mansoni, S. haematobium
and S. bovis are all conserved, especially when taking
into consideration the accepted standard primary AChE
(1EA5_A) sequence from the ray Torpedo californica. It
has been shown that the active site of T. californica
AChE consists of a catalytic triad (S200-H440-E327, in
red stars, Fig. 2) which lies close to the bottom of a deep
and narrow tertiary structure gorge, which is lined with
the rings of 14 aromatic amino acid residues [31]. The
conserved catalytic triad is present in S. japonicum
(S280-H54-E327), while the nine residues (W148, W186,
W193, Y202, W304, F371, F404, Y407, Y537, in dark red
triangles, Fig. 2) in the rings of the 14 aromatic amino
acid residues of T. californica AChE, are conserved in
the appropriate locations in SjAChE.
The tertiary protein structure for SjAChE was predicted
using Phyre2 (Fig. 3a). Model dimensions for SjAChE (Å)
(X:61.705 Y:62.361 Z:71.856) are the same as those of S.
haematobium AChE. Of note, we found four predicted N-
Acetylglucosamine (NAG) binding sites located at (i)
M123, D125; (ii) P423, K245, M428; (iii) R507-T510, P512;
and (iv) Q550-F551, A553-Y556 in SjAChE (Fig. 3b). N-
Acetylglucosamine, a monosaccharide derivative of glu-
cose, is directly incorporated into glycosaminoglycans and
glycoproteins, acting as a substrate for tissue repair mech-
anisms [32]. The predicted four NAG binding sites in
SjAChE are in line with previous findings which revealed
the presence of NAG in all forms of cholinesterases inves-
tigated [20], providing evidence for N-linked glycosylation
Fig. 1 Phylogenetic analysis of S. japonicum acetylcholinesterase and functionally characterised acetylcholinesterases from other taxa. Species
(Sequence Accession Number) used for the analysis include: Mus musculus (EDL19281), Bos taurus (NP_001069688), Homo sapiens (AAA68151),
Tetronarce californica (X03439), Xenopus tropicalis (XP_002931610), Ambigolimax valentianus (BAO00806), Crassostrea gigas (XP_011422197),
Caenorhabditis elegans (W09B12.1.1*), Hymenolepis microstoma (HmN_000644400*), Taenia solium (TsM_000001700*), Echinococcus granulosus
(EgrG_000732400*), Echinococcus multilocularis (EmuJ_000732400*), Clonorchis sinensis (csin108144*), Opisthorchis viverrini (T265_07137*), Fasciola
hepatica (BN1106_s773B000378), Schistosoma. haematobium (AF279462), S. bovis (AF279463), S. mansoni (AF279461). Note: *: Gene ID from WormBase
ParaSite web site (http://parasite.wormbase.org/Multi/Tools/Blast)
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Fig. 2 (See legend on next page.)
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in SjAChE. The predicted protein structure for SjAChE
also suggests that it may be fucosylated on the innermost
N-acetylglucosamine residue of the core [33].
Western-blot analysis
SDS-PAGE showed the purified rSjAChEC migrated as a
single band with the predicted size of 30 kDa (Fig. 3c).
The specificity of the rabbit anti-SjAChEC antibody was
confirmed as it bound a band of approximately 76 kDa
in adult S. japonicum SWAP, thereby matching well with
the calculated molecular size for SjAChE (Fig. 3c). Con-
trol serum from the pre-immunized control rabbit did
not bind any protein component in S. japonicum SWAP.
Distribution of SjAChE in adults and schistosomula
Indirect immunohistochemistry, incorporating HRP la-
belling, indicated that SjAChE immunoreactivity oc-
curred in the tegument, the underlying musculature but
also throughout the parenchyma and tissues of both
males (Fig. 4a) and females (Fig. 4b). To better
understand how the anti-SjAChE serum interacted with
schistosomula, we used immunofluorescence to show
SjAChE is also localized on the tegumental surface of
live 4-day-old schistosomula (Fig. 4d) and the paren-
chyma; the latter observation may be indicative of dam-
age to the schistosomula during labelling process. By
using two different immunolocalisation methods involv-
ing HRP labelling and immunofluorescence, we showed
a similar distribution of SjAChE in early (schistosomula)
and late (adult males and females) developmental stages
in the mammalian host.
Inhibition of SjAChE activity
SjAChE sensitivity to chemical inhibition, in extracts of
adult worms, was assessed by the pre-incubation of
tegument or carcass proteins with BW284c51 at a con-
centration range of 0–1,000 μM. SjAChE, present both
in the worm tegument or carcass extract, was sensitive
to BW284c51, and its activity exhibited a linear response
to concentration changes up to 1000 μM of BW284c51
(See figure on previous page.)
Fig. 2 Alignment of acetylcholinesterases from S. mansoni, S. haematobium, S. bovis, Homo sapiens and T. californica. Red boxes indicate the two
conserved subdomains including carboxylesterase type-B signature 2 (E156-P166) and carboxylesterase type-B serine active site (F258-G273). Sev-
eral motifs are found in SjAChE: N-glycosylation sites underlined (N42-I45, N171-H174, N314-Q317, N418-D421, N630-K633); N-myristoylation sites
boxed in purple (G71-Q76, G95-Q100, G298-N303, G305-E310, G395-E400, G532-Y537); Casein kinase II phosphorylation site boxed in brown (S88-
D91, S200-D203, S329-D332, S341-E344, T351-D354, T456-E459, S471-E474, T559-E562, T592-E595); Protein kinase C phosphorylation sites boxed in
blue (S105-R107, T316-R318, S379-R381, T473-R475, S481-K486, S631-K633) which are specific for schistosome; Tyrosine kinase phosphorylation site
boxed in green (R454-Y460); amidation site (P503-R506). The conserved catalytic active catalytic triad site is observed S. japonicum (S280-H54-
E327, in red stars), while the 9 residues (W148, W186, W193, Y202, W304, F371, F404, Y407, Y537, in dark red triangles) in the rings of 14 aromatic
amino acid residues of T. californica AChE are conserved in the appropriate locations in S. japonicum AChE. The coloured boxes which covered
only sequences from four species of schistosomes indicated the specific motifs for schistosome. Note: AChE from S. mansoni (SmAChE), S. haema-
tobium (ShAChE), S. bovis (SbAChE), Homo sapiens (HsAChE) and T. californica (TcAChE)
Fig. 3 a Three dimensional model of S. japonicum acetylcholinesterase determined using PHYRE2. Image coloured by rainbow from N to C
terminus, Model dimensions (Å) X: 61.705 Y: 62.361 Z: 71.856 are the same as that of ShAChE. b The predicted binding sites of SjAChE with N-
Acetylglucosamine (NAG). The four predicted N-Acetylglucosamine binding sites (in blue) are located at (i) M123, D125; (ii) P423, K245, M428; (iii)
R507-T510, P512; and (iv) Q550-F551, A553-Y556 in SjAChE. The NAG residues are shown in green. c Western blot analysis using anti- SjAChEC to
detect the total extracts from adult S. japonicum. Left panel: SDS-PAGE gel of purified recombinant protein SjAChEC (Molecular size: 30 Kda); Right
panel: western blot analysis of total extract from adult S. japonicum worms. The protein extract was probed with rabbit anti-SjAChEC antibody
(Lane 1) by recognising a band of approximately 76 kDa which match the calculated molecular size for native SjAChE Pre-immune sera (Lane 2)
was used as control. Lane M, PageRulerTM pre-stained protein ladder
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(Fig. 5a). SjAChE activity in the tegument extract was
significantly higher (about 10-fold; t-test, t = 1.881, df =
6, P < 0.0001) than in the carcasses of adult worms, sug-
gesting the majority of the enzyme is located on the
tegument of paired adult S. japonicum. The IC50 (50 %
inhibition) of BW284c51 on SjAChE in the tegumental
protein extract of adult worms occurred at a concentra-
tion of 16 μM which indicates a substantially higher sen-
sitivity than that reported for the AChEs from S.
mansoni, S. bovis and S. haematobium [2]. The sensitiv-
ity of SjAChE in the tegument and carcasses isolated
from cultured adult worms in the presence of 200 μM
BW284c51 (IC80, 80 % inhibitory concentration) are
shown in Fig. 5b. With the same concentration of tegu-
ment protein, paired worms had a higher SjAChE activ-
ity than single-sex worms (t-test, t = 3.903, df = 4, P =
0.0175) with male worms having a higher SjAChE activ-
ity than females (t-test, t = 18.66, df = 4, P < 0.0001).
After being treated with 200 μM BW284c51, the SjAChE
enzyme activity in tegument protein extracts of paired
worms, males and female worms decreased by 59 %,
22 % and 50 %, respectively (t-test, t = 40.52,; 17.28; and
39.56, respectively, df = 4, P < 0.0001). Compared with
the tegumental protein extract, there was much less
SjAChE activity in the carcass protein extract, with a
relatively higher activity in males compared with that in
pairs and females (t-test, t = 29.41 and 39.07, respect-
ively, df = 4, P < 0.0001), with the latter having the lowest
level of SjAChE activity. SjAChE activity in the carcass
protein extracts of males and paired worms was inhib-
ited by 77 % (t-test, t = 32.69, df = 4, P < 0.0001) and
45 % (t-test, t = 15.07, df = 4, P < 0.0001), respectively in
the presence of 200 μM BW284c51.
Discussion
Previous studies on AChE in schistosomes have focused
mainly on S. mansoni, S. haematobium and S. bovis and,
prior to this study, very limited information was avail-
able for the enzyme in S. japonicum. Here, we report the
cloning and expression of the complete cDNA encoding
S. japonicum AChE (SjAChE). To better understand its
functions, we performed sequence and phylogenetic ana-
lysis on SjAChE and predicted its tertiary molecular
structure. As might be expected, the protein has high
Fig. 4 Immunolocalisation of SjAChE in adult S. japonicum and four-day mechanically transformed schistosomula. Adult male a and female b
worm sections were labelled with rabbit anti-SjAChE antibody coupled with anti-rabbit HRP and scanned using an Aperio scanner. c Negative
control sections of female worm were incubated with rabbit pre-immune serum. The female gut (b, c) appears non-specifically opaque due to
the presence of red blood cell products, with the histochemical negative control demonstrating the dark region is due to gut contents.
d Immunofluorescence of SjAChE in four-day old schistosomula probed with rabbit anti-SjAChE antibody. e Brightfield and corresponding fluorescence
images f of schistosomula negative controls using pre-immune rabbit serum. Donkey anti-rabbit IgG 555 was used as secondary antibody and positive
immunofluorescence is shown in red. As a negative control, f shows there is no signal produced when incubating parasites with rabbit pre-immune
serum in the adult worm tissue. Scale-bars: a-c, 100 μm; d-f, 20 μm
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sequence identity (88 %) with the AChEs in S. mansoni,
S. haematobium and S. bovis. The key residues that are
important for the formation of the three disulphide
bonds and two salt bridges characteristic of AChE [29],
in substrate binding and for catalytic activity are con-
served across the four species. These residues comprise
important structural features including the peripheral
anionic site [27], the catalytic triad [28] and residues that
line the catalytic gorge [29]. One particularly noteworthy
feature of the AChE protein sequence in schistosomes is
two “missing” residues that form part of the peripheral
active site. Within the AChE of Torpedo californica, resi-
due F330 has a neighbouring F residue in the same sec-
ondary structure that is not indicated as playing a role in
the catalysis of acetylcholine. However, whereas in schis-
tosomes, the equivalent of F330 is not present (Fig. 2),
the neighbouring F residue is. It may be possible that
this neighbouring F residue has taken over the catalytic
role, or that this role has been lost altogether in schisto-
somes. Similarly, an equivalent residue could not be
found at the position expected for W279 (Fig. 2), an-
other peripheral active site residue. Considering these
residues are only part of the peripheral active site, they
may not be essential for the function of AChE in schisto-
somes and have been lost over time through mutational
events.
As with the other schistosomes, immunolocalisation
showed that SjAChE is located on the tegumental sur-
face and parenchyma of adult worms and 4-day-old
schistosomula [2]. Previous work showed the existence
of two principal molecular forms (external and internal)
of S. mansoni AChE, with approximately half of the
AChE activity being found on the tegumental membrane
via a covalently attached glycosylphosphatidylinositol
(GPI) anchor and which may function in signal trans-
duction, with the remainder mainly associated with
muscle tissue and involved in cholinergic processes [34].
These two forms of AChE were also shown to differ in
their heparin-binding properties (only the internal form
interacted with heparin) and in immunological specifi-
city (being located on the surface the GPI-anchored
form may be susceptible as an immunological target)
[35]. Further investigation is required to determine
whether there are also different molecular forms of
SjAChE and if so whether they have discrete functional
roles in S. japonicum.
To quantify the relative activity of SjAChE present
within the tegument and in the musculature of adult S.
japonicum, we separated the tegumental protein from
the parasite carcass, and performed enzyme activity as-
says. We found that most of the SjAChE activity was
concentrated in the tegument, having 10-fold the activity
of the carcass (Fig. 5a), suggesting that SjAChE has po-
tential as a drug or immunological target. We also
showed that SjAChE activity was highly enriched in the
male tegument and this observation is understandable as
male parasites, being larger in size, and having an in-
creased tegumental volume [36]. One established func-
tion of tegumental AChE in schistosomes is in the
regulation of glucose uptake across the tegument in
Fig. 5 Inhibition of AChE activity in adult Schistosoma japonicum protein preparations or intact worms. a SjAChE activity in the tegument extract
was significantly higher (about 10-fold; P < 0.0001) than in the carcasses of adult worms. The IC50 (50 % inhibition) of BW284c51 on SjAChE in the
tegumental protein extract of adult worms is indicated as dotted lines at a concentration of 16 μM. b The sensitivity of SjAChE in the tegument
and carcasses, isolated from cultured male and female worms in the presence of 200 μM BW284c51, were different. At the same concentration of
tegument protein, paired worms had higher SjAChE activity than single-sex worms with male worms (P = 0.0175) having a higher SjAChE activity
than females (P < 0.0001). After treatment with BW284c51, SjAChE enzyme activity in tegument protein extracts of paired worms, male worms
and female worms decreased by 59 %, 22 % and 50 %, respectively (P < 0.0001). Compared with the tegumental protein extract, there was much
less SjAChE activity in the carcass protein extract, with a relatively higher activity in males. Error bars represent the standard error of the mean
(SEM). These experiments were performed three times (n = 3). Relative activity (%) = 100 × (sample fluorescence – negative fluorescence)/(positive–
negative fluorescence). *P≤ 0.05, **P≤ 0.001, ***P≤ 0.0001
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response to ACh present in the mammalian host blood-
stream [7]. Given that male schistosomes play a more
important role in host glucose uptake [37], it is reason-
able to consider that AChE activity would also be higher
in male S. japonicum, as we have shown. The distribution
of AChE in S. japonicum we established correlates with
that reported in the other schistosome species [13, 38].
It has been shown that AChE activity and its sensitiv-
ity to the inhibitor BW284c51 is dependent on the rela-
tive amount of AChE expressed on the surface of adult
schistosomes [2], since the inhibitor does not readily
penetrate membranes of the adult worms [2]. We
showed a protein extract of the tegument of adult S.
japonicum had an IC50 with BW284c51 of 16 μM,
which is much lower than the reported IC50 for other
schistosome species (0.1–5.0 mM) [2]. Those results
may reflect a relatively larger amount of AChE activity
presented on the surface of adult S. japonicum compared
to the other schistosome species, indicating the AChE
inhibitor may be more effective against S. japonicum.
We also found that live adults of S. japonicum incubated
with Bw284c51 (200 μM) displayed reduced AChE activ-
ity in tegumental protein by 50 % in females, but only
22 % in males, suggesting that AChE present on the sur-
face of females is more sensitive to the inhibitor than
that on males. Previous work has shown that AChE is
associated with the AChR on cell surfaces [39] and in
schistosomes the expression of AChR is increased in
sexually paired worms when female parasites mature
into the egg producing stage [13]. The increased level of
AChR expression may require increased AChE activity
on the surface of female worms to maintain cholinester-
ase receptor fidelity. A similar situation occurred in
paired worms, where a 59 % decrease in SjAChE activity
was observed when paired incubated worms were
treated with 200 μM of Bw284c51.
The relatively high level of SjAChE activity distributed
within the carcass protein of males, when compared
with female and paired worms, may be indicative of its
involvement in muscle function [34], since male worms
have more muscle tissue. The SjAChE activity in male
carcasses was decreased by 77 % after incubation of live
male parasites with BW284c51 for 24 h, suggesting that
the inhibitor can penetrate the tegument of male S. japo-
nicum, which is a contradiction to previous reports stat-
ing the inhibitor cannot cross membranes [2].
It has been reported that AChE expression is induced
during apoptosis and is regulated by the mobilization of
intracellular Ca2+ in various mammalian cell types [40].
Promoting apoptosis appeared to be a feature of the
mode of action of two already established anti-
schistosomal drugs, the artemisinins [41] and praziquan-
tel [42], and drug targeting schistosome AChE may also
be effective by inducing apoptosis. Further, it has been
demonstrated that purified polyclonal antibodies raised
against S. mansoni AChE were cytotoxic and caused al-
most total complement-dependent killing of parasites in
vitro [9, 35], while not cross-reacting with human AChE.
This observation and the results presented here
strengthen the view that immunological targeting of
schistosome AChEs may be a highly suitable avenue for
future vaccine development and the prevention of
schistosomiasis.
Conclusions
In this paper, we have described the phylogenetic and
molecular/structural characterisation of the AChE pro-
tein from S. japonicum. These findings improved the un-
derstanding of the biological function of AChE in
schistosomes. The relative abundance of AChE activity
(90 %) present on the surface of adult S. japonicum
when compared with that reported in other schisto-
somes, suggests SjAChE may be a more effective drug or
immunological target against thus species. Furthermore,
we show that the AChE activity in tegumental extracts
of adult S. japonicum can be significantly inhibited by
the classical inhibitor of AChE (BW285c51) after incu-
bation with adult worms. The results we present support
the potential of AChE as a future drug target against S.
japonicum and also strengthens the view that immuno-
logical targeting of schistosome AChEs may be a highly
suitable avenue for future vaccine development and the
prevention of schistosomiasis.
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